FMC Q3 Earnings Call Highlights

FMC reported Q3 revenue of $1.06B, including $639M from commercial actions, and adjusted EBITDA of -$559M. Q4 outlook was lowered, with revenue expected at $1.04B-$1.14B and adjusted EBITDA at $210M-$230M. FMC cited market challenges and pricing headwinds. The company expects full-year free cash flow to be -$350M to -$150M, including restructuring spending. FMC also announced preliminary 2027 and 2028 adjusted EBITDA targets of $650M-$730M and $760M-$840M, respectively.

Original reporting
Published Oct 30, 2026, 8:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
FMC Q3 Earnings Call Highlights — source image
Decision brief

The 30-second read

$FMCBearishHigh
01

Why it matters

The earnings miss and lowered guidance are likely to trigger a sell‑off in FMC shares and may influence peer valuations.

02

Market read

FMC's earnings and guidance revision are material for traders with exposure to agriscience equities.

03

What to watch

New product launches and Brazil direct‑to‑grower sales could offset short‑term weakness.

Relevance 9/10Novelty 9/10Timing: post-earnings today

Background

FMC is a leading agricultural sciences company reporting its Q3 results and revising its Q4 outlook.

Company-level read

Ticker impact

$FMCBearishHigh confidence
Context

Q3 earnings released with revenue, EBITDA, EPS numbers and lowered Q4 guidance.

Expected impact

likely downside as market prices in lower earnings and guidance

Evidence & confidence

Adjusted EBITDA and EPS were negative; revenue guidance cut and higher restructuring spend signal weaker performance.

Market effects

Agricultural chemicals sector may see broader pressure from FMC's guidance downgrade.

Potential impact on North American and European ag‑input markets.

Limited to investors with exposure to FMC and related agriscience stocks.

Counterpoint

If FMC's restructuring and pricing actions succeed, upside could materialize later in the year.

Key entities

  • FMC Corporation

    Agricultural sciences firm reporting Q3 earnings.

  • Tessenderlo Group

    Increased its stake to ~20% following a $403 million equity investment.

Related articles

$FMCHigh

KeyBanc downgrades FMC stock rating on turnaround concerns

KeyBanc downgraded FMC Corp. (NYSE:FMC) to Sector Weight, citing risks to its turnaround efforts. The stock, at $5.21, has fallen 61.5% in a year. KeyBanc set a fair value of $5.50, while InvestingPro's analysis suggests a Fair Value of $6.36. FMC plans to raise $1 billion, including $400 million in equity, and anticipates a return to growth in 2027. Jefferies initiated coverage with a Hold rating and a $6.00 price target.

$FMCMed

Fresenius Medical cuts top end of 2026 profit outlook

Fresenius Medical Care adjusted its 2026 operating income outlook, now expecting a flat to mid-single-digit percentage decline, down from a previous range of decline to increase. Q3 operating income fell 5% to €545 million, while revenue grew 1% to €4.94 billion. US same-market treatments declined 1.1%. The company faces regulatory and inflation challenges under new CEO Shervin J. Korangy.

$FMCHighAI 8/10

Why FMC Corporation Rallied Today

FMC Corporation (NYSE:FMC) shares surged 30.4% after Q3 earnings, despite an 80% revenue drop to $106M and a loss of $4.41 per share. The decline was partly due to one-time price cuts and accounting adjustments. Management guided Q4 revenue to $1.11B and positive EBITDA of $220M, with expectations of $650M EBITDA in 2024 and $760M in 2028.

$FMCHighAI 8/10

FMC (FMC) Q3 2026 Earnings Call Transcript

FMC reported Q3 2026 earnings, including a $672M EBITDA impact from commercial actions. Revenue was $106M, with underlying sales at $745M, below guidance. Adjusted EBITDA was negative $559M. The company is changing its North America business model and adjusting prices to reduce channel inventory. Q4 revenue is expected to be $1.04B-$1.14B, with adjusted EBITDA between $210M-$230M.

$FMCHighAI 9/10

Why is FMC stock surging today?

FMC Corporation (FMC) stock rose 23.6% after reporting a Q3 2026 loss of $2.07 billion, largely due to a $639 million restructuring charge. Investors focused on improved cash flow and management's multi-year recovery outlook, with Q4 revenue guidance of $1.04B-$1.14B. Barclays maintained a Sell rating with a $4.00 target. The broader market declined, but FMC's rally was driven by short covering and relief.